Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation

Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation

Background: The success of immunotherapy for patients with hepatocellular carcinoma (HCC) suggests that immune dysregulation occurs in HCC patients. This warrants an immuno-oncological risk assessment in the platform of liver transplantation. Methods: This retrospective single-center study analyzed...

Full description

Bibliographic Details
Main Authors: Cheng-Maw Ho, Rey-Heng Hu, Yao-Ming Wu, Ming-Chih Ho, Po-Huang Lee
Format: Article
Language:English
Published: SAGE Publishing 2020-12-01
Series:Clinical Medicine Insights: Oncology
Online Access:https://doi.org/10.1177/1179554920968774

Similar Items

Similar Items